NATCO announces 30% rise in revenues

RELATED NEWS Natco Pharma Q2 net up at Rs 9.76cr Natco Pharma may form new entity for R&D Buy Natco Pharma at Rs 115: Tulsian Natco Pharma defers buyback schedule ALSO READ See latest News about Natco Pharma See previous management interviews See what other Experts & Brokerages are saying about Natco Pharma Natco Pharma BSE | NSE 10/02/12 Are Mutual Funds betting on Natco Pharma?

The Board of Directors of NATCO Pharma Limited, which met at Hyderabad today, had taken on record the working results for the quarter / half year ended on 30^th September, 2006.    The following are the highlights of the results :

 

Half year ended on 30^th September, 2006 :

 

For the half year ended on 30^th September, 2006, as compared to the half year ended on 30^th September, 2005, the revenues have gone up by 32% (from Rs. 100 Crores in financial year 2005-2006 to Rs. 132 Crores -  consolidated - for the financial year 2006-2007). The main drivers for revenues were the US retail business and the oncology formulations in the domestic market.

 

The profits, after tax, have gone up by 28% - from Rs. 1399 lakhs in the first half of the financial year 2005-2006 to Rs. 2081 lakhs during the corresponding period in the current financial year.  

 

Quarter ended on 30^th September, 2006 :

 

Revenues for the second quarter in the current year have gone up by 24% as compared to the last year (from Rs. 54 Crores to Rs. 63 Crores - consolidated). The post tax profit for the second quarter in the current year stood at Rs. 976 lakhs, as compared to Rs. 838 lakhs last year, recording an increase of 17%.

 

Contd on page 2...